Dr. Rosen's laboratory examines apoptotic and cell signaling pathways in the lung with a focus on fibrotic lung disease and lung cancer.

Dr. Rose's research investigates early brain and motor development in preterm children and the neuromuscular mechanisms underlying motor deficits in children with cerebral palsy.

Dr. Robinson's lab studies the molecular mechanisms of and develops therapies to treat autoimmune and rheumatic diseases, with a focus on rheumatoid arthritis, multiple sclerosis, and osteoarthritis.

Dr. Rogers's group uses genetics and genomics methodologies to identify novel ARDS pathobiology; they hope that this will enable identification of novel biomarkers, phenotypes, and treatments for the disease.

Dr. Rohatgi's laboratory are working to elucidate the biochemical and cell biological principles that govern signaling pathways that sit at the intersection between developmental biology and cancer.

The Ricci lab uses advanced electrophysiologic, imaging, molecular and pharmacologic techniques to probe mechanisms of mechanotransduction and synaptic transmission at the auditory periphery.

Dr. Relman's primary research focus is the human indigenous microbiota, and in particular, the nature and mechanisms of variation in patterns of microbial diversity within the human body as a function of time, space, and in response to perturbation, e.g., antibiotics.

Dr. Reiss studies how genetic and environmental factors affect brain structure and function, and how this ultimately impacts the development and function of persons with these disorders.

Dr. Reimer's lab has two primary interests: neurotransmitter recycling and lysosomal storage disorders.

Dr. Red-Horse's laboratory uses cardiovascular development as a model to study the signals that instruct cell fate and guide morphogenesis during organ formation in the mammalian embryo.